INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 5.10
-0.05 (-0.97%)
At close: Jun 3, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 548.12 million as of June 4, 2026. Its market cap has increased by 6.87% in one year.
Market Cap
548.12M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 548.12M, an increase of 21.17%. That is a compound annual growth rate of 4.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 548.12M | 43.53% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.17B |
| Nordhealth AS | 2.16B |
| Circio Holding ASA | 1.99B |
| Photocure ASA | 1.65B |
| Nykode Therapeutics AS | 1.02B |
| Vistin Pharma ASA | 931.24M |
| Lytix Biopharma ASA | 811.30M |
| Omda AS | 717.77M |